Patents for A61P 17 - Drugs for dermatological disorders (106,455)
07/2012
07/04/2012CN101768516B Tangerine oil and preparation method and application thereof
07/04/2012CN101744976B Sterilizing and antipruritic lotion and preparation method thereof
07/04/2012CN101744795B Medicinal composition for treating nevus flammeus and preparation method thereof
07/04/2012CN101724934B Medicinal fibre used for treating cutaneous inflammation and pain, preparation and application thereof
07/04/2012CN101683427B Traditional Chinese medicine composition and preparation method thereof
07/04/2012CN101632685B Application of aldehyde-modified polysaccharide containing carboxyl to preparing medicine and medical material
07/04/2012CN101623297B Medicine for treating beriberi
07/04/2012CN101601652B Momestasone furoate lipidosome cream
07/04/2012CN101591368B Girald pteroxygonum root neoflavonoid compound
07/04/2012CN101574392B Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid
07/04/2012CN101513405B Use of chemotherapeutic agents
07/04/2012CN101474156B Vitamin C precursor liposome and preparation method thereof
07/04/2012CN101401885B Liquid medicine for removing miliaria and preparation method thereof
07/04/2012CN101385811B Medicament for treating psoriasis
07/04/2012CN101385800B Skin-protection scream for foot
07/04/2012CN101385799B Chinese herbal medicine for treating empyrosis
07/04/2012CN101385791B Leukoderma treating medicine
07/04/2012CN101322760B Compound Chinese herbal medicine formulation for treating causative pathogen skin ulcerative syndrome of Apostichopus japonicus
07/04/2012CN101228911B Tea for nourishing face and eliminating toxin
07/04/2012CN101209344B Application of hyperosmotic fluid composition in preparing medicament for improving wound healing
07/04/2012CN101115763B Novel polyphenol glycoside derived from acerola
07/03/2012US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2475106C Use of cyclopentane heptanoic acid derivatives for enhancing hair growth
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2471041C Compositions and methods for enhancing corticosteriod delivery
07/03/2012CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
07/03/2012CA2388818C C-aryl glucoside sglt2 inhibitors and method
07/03/2012CA2370805C Ureas as cell adhesion modulators
06/2012
06/28/2012WO2012088382A2 Amyris alcohol and its ester for treating acne
06/28/2012WO2012088210A2 Methods and compositions for wound treatment
06/28/2012WO2012087823A2 Ph-induced silk fibroin gels and uses thereof
06/28/2012WO2012087289A1 Halogenated biphenols as antibacterial agents
06/28/2012WO2012086760A1 Disinfectant
06/28/2012WO2012085559A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
06/28/2012WO2012085483A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
06/28/2012WO2012085481A1 Dermatological foams obtained from a gel or suspension containing adapalene
06/28/2012WO2012085244A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
06/28/2012WO2012085230A1 Extract of the above-ground portions of gynandropsis gynandra or cleome gynandra, and cosmetic, dermatological or pharmaceutical compositions including same
06/28/2012WO2012085226A1 Extract of aerial parts of maca rich in polyphenols and composition comprising same
06/28/2012WO2012085224A1 Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
06/28/2012WO2012085182A1 Novel bacterium and extracts of said bacterium and the use of same in dermatology
06/28/2012WO2012084978A1 (r)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
06/28/2012WO2012084870A1 Modulators and methods for the treatment of rosacea
06/28/2012WO2012084869A1 Modulators of trpa1 for the treatment of rosacea
06/28/2012WO2012083397A1 Guanabenz-containing compound for the treatment of primary cutaneous amyloidosis
06/28/2012WO2012083385A1 Serine protease inhibitors
06/28/2012WO2012083341A1 Composition for the treatment of skin conditions
06/28/2012WO2012061630A3 Composition and method for treating skin conditions
06/28/2012WO2012045072A3 Sugar-based dispersion
06/28/2012WO2012033368A3 Composition containing prunus mume extract for external application to the skin
06/28/2012US20120165409 Wrinkle-improving agent
06/28/2012US20120165408 Oral composition for alleviating rough skin
06/28/2012US20120165406 Bis-trifluoromethyl honokiol analogs and their use in treating cancers
06/28/2012US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/28/2012US20120165379 Allantoin-containing skin cream
06/28/2012US20120165373 Method of Treating Skin with microRNA Modulators
06/28/2012US20120165372 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
06/28/2012US20120165368 Pyrazolopyridine kinase inhibitors
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165357 Compositions Containing Berberine or Analogs Thereof for Treating Rosacea or Red Face Related Skin Disorders
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165322 Rho kinase inhibitors
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165319 Inhibitors of interleukin-1 beta converting enzyme
06/28/2012US20120165311 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
06/28/2012US20120165307 Azaindoles useful as inhibitors of janus kinases
06/28/2012US20120165301 Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/28/2012US20120165293 Synthesis of prostanoids
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165291 Acidic composition for external use and agent for accelerating infiltration of cosmetic preparation, hair-growing agent, and preparation for external use each containing the composition into skin or the like
06/28/2012US20120165284 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis
06/28/2012US20120165270 Inhibition of hair follicle growth by the wnt inhibitor dkk1
06/28/2012US20120164250 Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosporylation of mitogen-activated protein kinase using flemingia macrophylla extract
06/28/2012US20120164248 Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
06/28/2012US20120164246 One or more of Vigna marina, Cocos nucifera L. or Terminalia catappa L. extracts for treating wounds, skin disorders and hair loss
06/28/2012US20120164242 Novel methods for modulating melanin production
06/28/2012US20120164235 Hydrogel formulation comprising oxidative reductive potential water
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164152 Anti-il-17f antibodies and methods of use thereof
06/28/2012US20120164131 Modified mutant collagenase and it's use in fat melting and in scar reduction
06/28/2012US20120164116 Compositions and methods for tissue filling and regeneration
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012US20120164113 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
06/28/2012US20120164109 nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
06/28/2012US20120164087 Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012DE102010056192A1 Kolloidales Trägersystem mit penetrierenden Eigenschaften zum Einschließen lipophiler Wirkstoffe und Öle für die topische Anwendung Colloidal carrier system with penetrating properties to entrap lipophilic active ingredients or oils for topical application
06/28/2012DE102010055771A1 Composition useful as a medicament for therapeutic, prophylactic, cosmetic or health-promoting functions in e.g. humans comprises chlorite and polyvalent alcohol in aqueous or alcoholic-aqueous chlorine dioxide-containing solution
06/28/2012CA2822725A1 Modulators and methods for the treatment of rosacea
06/28/2012CA2822723A1 Modulators of trpa1 for the treatment of rosacea
06/28/2012CA2822547A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
06/28/2012CA2822546A1 Dermatological foams obtained from a gel or suspension containing adapalene